Cargando…

Longer recurrence‐free survival in a patient with metastatic renal cell carcinoma treated with temsirolimus

Temsirolimus did not demonstrate an efficacy advantage compared with sorafenib as second‐line therapy in patients with metastatic renal cell carcinoma (mRCC). Only a few patients achieved complete responses, and the median progression‐free survival rate remains short. We report one patient with mRCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satoh, Tendo, Koie, Takuya, Horiguchi, Hirotaka, Tokui, Noriko, Narita, Satoshi, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715416/ https://www.ncbi.nlm.nih.gov/pubmed/29225833 http://dx.doi.org/10.1002/ccr3.1181

Ejemplares similares

Unexpected outcome after sclerotherapy of simple renal cyst
por: Hashimoto, Yasuhiro, et al.
Publicado: (2012)

Tubulocystic renal cell carcinoma in the left kidney: a case report
por: Ishibashi, Yusuke, et al.
Publicado: (2014)

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma
por: Lee, Jii Bum, et al.
Publicado: (2019)

Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy
por: Iwamura, Hiromichi, et al.
Publicado: (2014)

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma
por: Ozaki, Kai, et al.
Publicado: (2021)

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient
por: Narita, Takuya, et al.
Publicado: (2014)

Temsirolimus for patients with metastatic renal cell carcinoma: outcomes in patients receiving temsirolimus within a compassionate use program in a tertiary referral center
por: Afshar, Mehran, et al.
Publicado: (2014)

Preoperative Butyrylcholinesterase Level as an Independent Predictor of Overall Survival in Clear Cell Renal Cell Carcinoma Patients Treated with Nephrectomy
por: Koie, Takuya, et al.
Publicado: (2014)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report
por: JURADO, JOSÉ MIGUEL, et al.
Publicado: (2013)

Metastatic clear cell renal carcinoma – an unusual response to Temsirolimus in second line therapy
por: Stanculeanu, DL, et al.
Publicado: (2016)

Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report
por: Tanaka, Yoshimi, et al.
Publicado: (2013)

Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Profile of temsirolimus in the treatment of advanced renal cell carcinoma
por: Staehler, Michael, et al.
Publicado: (2010)

Renal Cell Carcinoma: Focus on Safety and Efficacy of Temsirolimus
por: Hadoux, Julien, et al.
Publicado: (2010)

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
por: Kojima, Yuta, et al.
Publicado: (2015)

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
por: Hatakeyama, Shingo, et al.
Publicado: (2011)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
por: Kaley, Thomas J., et al.
Publicado: (2020)

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma
por: Ness, Dylan B., et al.
Publicado: (2023)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
por: Verschraegen, Claire F., et al.
Publicado: (2013)

A Case of Primary Renal Carcinoid Tumor
por: Tanaka, Toshikazu, et al.
Publicado: (2015)

A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma
por: Jobard, Elodie, et al.
Publicado: (2015)

Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis
por: Goudarzi, Zahra, et al.
Publicado: (2023)

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

A Case of Malignant Pheochromocytoma Detected during Fertility Treatment
por: Hagiwara, Kazuhisa, et al.
Publicado: (2014)

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation
por: Kodama, Hirotake, et al.
Publicado: (2018)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
por: Hatakeyama, Shingo, et al.
Publicado: (2012)

Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center
por: Hatakeyama, Shingo, et al.
Publicado: (2013)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Robotic cross‐folded U‐configuration intracorporeal ileal neobladder for muscle‐invasive bladder cancer: Initial experience and functional outcomes
por: Koie, Takuya, et al.
Publicado: (2018)

Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
por: Pulido, Marina, et al.
Publicado: (2018)

Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma
por: Horiguchi, Hirotaka, et al.
Publicado: (2018)

Evaluating the activity of temsirolimus in neuroendocrine cancer
por: O'Donnell, P H, et al.
Publicado: (2007)

Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
por: Zardavas, Dimitrios, et al.
Publicado: (2011)

Renal cell carcinoma in a lumbar ectopic kidney
por: Hamano, Itsuto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n11rtk7cepe4v6lqnifnjutovp